ABUS NASDAQ
Arbutus Biopharma Corp
1W: -8.2%
1M: -12.8%
3M: -10.5%
YTD: -6.7%
1Y: -3.0%
3Y: +121.4%
5Y: -3.7%
$4.45
-0.11 (-2.41%)
Weekly Expected Move ±3.6%
$4
$4
$4
$5
$5
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$182M
Revenue
+1078.8% YoY
$153M
Net Income
+382.1% YoY
$-25M
Free Cash Flow
+59.1% YoY
100.0%
Gross Margin
-588.2%
Op. Margin
-507.2%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE89.6%
ROA81.1%
ROIC86.7%
Valuation
P/E5.6
P/B3.4
EV/EBITDA5.6
Leverage
Debt/Equity0.01
Current Ratio81.42
Interest Cov.2014.9x
Quality Scores
Piotroski F4/9
Altman Z34.67
Beneish M1705.68